PharmaLive (press release) (subscription) MGN1703 is based on dSLIM® (“double Stem Loop Immunomodulator ”), an innovative DNA-based TLR9 agonist developed by MOLOGEN. dSLIM® activates the immune system against tumor-associated antigens by targeting various receptors on certain ...
GlobeNewswire (press release) Extensive clinical research has demonstrated that PURACERE™, the active ingredient in our new product lines, is a naturally powerful immunomodulator . The new iNR Wellness, iNR Wellness MD, and iNR Strength products can provide benefits to ...
Wall Street Journal Laquinimod is an oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed for the treatment of relapsing-remitting MS. The global Phase III clinical development program evaluating oral laquinimod in MS includes ...
4-traders (press release) Laquinimod is an oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed for the treatment of relapsing-remitting MS. The global Phase III clinical development program evaluating oral laquinimod in MS includes ... and more »
DailyFinance Aubagio is an immunomodulator with anti-inflammatory properties. Although the exact mechanism of action for Aubagio is not fully understood, it may involve a reduction in the number of activated lymphocytes in the central nervous system (CNS). Aubagio ... and more »
MENAFN.COM Extensive clinicalresearch has demonstrated that PURACERE(TM), the active ingredient inour new product lines, is a naturally powerful immunomodulator . Thenew iNR Wellness, iNR Wellness MD, and iNR Strength products canprovide benefits to ... and more »
